Rich Segal, R.Ph., Ph.D. Professor and Associate Dean University of Florida

Similar documents
National Asthma Educator Certification Board Detailed Content Outline

Public Dissemination

Interventions to improve adherence to inhaled steroids for asthma. Respiratory department

Adverse outcome + process of care. Outline. Outline of a Medication Use System. Review. Performance Indicator Format. System Performance Information

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

A Process for Performing Medication Assessments

Office Asthma Care: Practical Elements of Asthma Management. Learning Objectives. Diagnosis

Community Pharmacy Asthma Audit 2016/17. Contents

10/24/2016. An Asthma Telehealth Program to Improve Adherence to Inhaled Corticosteroid Therapy. Disclosures. Overview of Presentation

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

SAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND. Sandra Brownstein, PharmD, CGP

Project 3dii: Expansion of the Home Environmental Asthma Management Program

PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S.

Florida MEDS-AD Waiver

Florida MEDS-AD Waiver

Comprehensive Medication History Interview Form

Minimum Competencies for Asthma Care in Schools: School Nurse

Methods to Diagnose Adherence Status

Patient Education at the Point of Dispensing Improves Adherence and Increases Sales

Patient Information ARNUITY ELLIPTA (ar-new-i-te e-lip-ta) (fluticasone furoate inhalation powder) for oral inhalation use What is ARNUITY ELLIPTA?

Title Page. Title Behavioral Influences on Controller Inhaler Use for Persistent Asthma in a Patient-Centered Medical Home

Digital Technologies: The Solutions to Poor Medication Adherence?

beclometasone 100 MDI 2 puffs twice a day (recently changed to non CFC (Clenil Modulite))

Character of pharmaceutical care

PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 11/16/17 SECTION: DRUGS LAST REVIEW DATE: 11/16/17 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

PEDIATRIC ASTHMA INPATIENT CARE MAP

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article

Learning Outcomes 1. Identify key U.S. drug regulations that have provided guidelines for the safe and effective use of drugs and drug therapy.

Disclosure. Learning Objectives 6/4/2014. Medication Adherence: Challenges and Opportunities

Rosemary Plum Prescriptive Solutions Ltd SIMPLE Respiratory 2015

Improving the Management of Asthma to Improve Patient Adherence and Outcomes

Patient adherence to inhaled therapy A clinical perspective. Nicolas Roche Cochin, Site Val de Grâce University Paris Descartes, Paris, France

Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands

A COMPREHENSIVE APPROACH TO MANAGING DIABETES

PHARMACIST INVOLVEMENT IN HIV CARE. Alftan D. Dyson, Pharm.D., BCACP, AAHIVP Clinical Pharmacist, Medical Advocacy and Outreach

Asthma Medications: Information for Children and Families. What You Need to Know about Medicines for Asthma

Medication Therapy Management: Improving Health and Saving Money

PATIENT INFORMATION BREO ELLIPTA

Research activity following Asthma Treatment Uncertainty Priority Setting Exercise in 2007 paper updated January 2010

HELPING LIFT YOU THROUGH YOUR JOURNEY WITH SYMPTOMATIC SARCOIDOSIS

WHAT IS STRESS? ( C ) L A Y L A C A S S I M E R S C O N S U L T A N T S C C,

Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma

Suggested Classroom Activity: Have the students access the FDA.gov website for the

Approved Care Model for Project 3dii: Expansion of the Home Environmental Asthma Management Program

Safe Medication Use. Patient Teaching Slides

Practical Medicines Management

Drug Prior Authorization Guideline NUCALA (mepolizumab)

Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

Asthma and Adherence to Inhaled Corticosteroids: Current Status and Future Perspectives

Start your patient s drug education

On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children

ASTHMA CARE FOR CHILDREN BASKET OF CARE SUBCOMMITTEE Report to: Minnesota Department of Health. June 22, 2009

Safe, effective, affordable drug choices: online tool for payers and patients.

To Take or Not To Take?

CONVERSATION STARTERS: ENGAGING YOUR PATIENTS AT PICK UP JULY 12, :00 2:30 PM

Because the more you know, the better you ll feel.

ADASUVE (LOXAPINE) INHALATION POWDER. EDUCATION PROGRAM for HEALTHCARE PROFESSIONALS

Clinical Practice Guideline: Asthma

MEDICINES ADHERENCE The Role of the Pharmacist

Leeds West CCG Paediatric asthma project. January 2015-January 2017

Strategies for Managing Your Medications

Because the more you know, the better you ll feel.

PCNE Classification PCNE scheme for Drug related problems-2

Student Paper PHARMACY PRACTICE. Keywords: asthma, inhalers, patient education

Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region

Plymouth Pharmacy Inhaler Use Review Pilot March 2018

Role of the Clinical Pharmacist in Primary Care

Recommended Component: Assure Immediate Access to Medications as Prescribed

PATIENT-IMPACT SCORECARD

Chapter 7. M.G.Rajanandh, Department of Pharmacy Practice, SRM College of Pharmacy, SRM University.

Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star

MEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL

Patient Information ALVESCO [ael- ves-koʊ] (ciclesonide) Inhalation Aerosol. Do not use your ALVESCO Inhalation Aerosol near heat or an open flame.

9/25/15. Pharmacy Quality Measures: Financial Support. Learning Objectives. Speaker Disclosure. Access to Preferred Networks and Clinical Performance

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder

Like others here today, we are very conflicted on the FDA s proposal on behind-thecounter medications, but thank you for raising the issue.

April 10 th, Bond Street, Toronto ON, M5B 1W8

Guidance for Pharmacists on Safe Supply of Oral Methotrexate

Asthma: Bronchodilator Overuse Review (MOPS Accredited until August 2020)

Medication Use safety Training FOR SENIORS

ONBREZ BREEZHALER should only be used to treat COPD.

CME/CE POSTTEST CME/CE QUESTIONS

ASTHMA EXACERBATIONS:

PATIENT INFORMATION. ADVAIR DISKUS [AD vair DISK us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation

PATIENT INFORMATION LEAFLET

Leveraging Information Technology for Evidence-Based Design. December 15, 2005

XOLAIR (omalizumab) Prior Authorization

A Pharmacist s Guide to Intermezzo

MEDICAL ASSISTANCE BULLETIN

New inhaler monitoring technologies: what they do and how they are used

The Self-Medication Assessment Tool (SMAT) Training Program

Asthma: Evaluate and Improve Your Practice

Opiate Use Disorder and Opiate Overdose

Case-Compare Impact Report

Furthermore, medications dispensed by physicians often cost more for the payer than the same medication dispensed by a retail pharmacy.

Adepu and Adusumilli: Drug-related Problems in Patients with Chronic Diseases in South India

Medicines Optimisation Strategy

Michael S. Blaiss, MD

Asthma MTM Pilot Checklist

Transcription:

Exploring Barriers to Medication Adherence and Strategies for Improving Adherence for Asthma Rich Segal, R.Ph., Ph.D. Professor and Associate Dean University of Florida

Presentation Objectives Understand how people with asthma actually use the medications prescribed for them as well as use of self-medication Identify barriers to medication adherence Describe the effectiveness of pharmacists, physicians, and other healthcare personnel in addressing adherence barriers Identify strategies for resolving barriers to medication adherence.

4

Drug Related Medical Accidents are Responsible for How Many Deaths? Tip of the Iceberg! 76,000 to >100,000 deaths from ADRs in U.S. Hospitals Alone What about those in Community Settings?

Objectives of Beneficent Care Not to inflict harm To prevent harm To remove harm To promote good 6

Simplified Medication Use Process Recognize Patient Problem Clinical Impression (Diagnosis) PLAN Prescribe Medicine Drug Related Morbidity Drug Therapy Problem Develops IMPLEMENT PLAN (Dispense and Advise) IMPLEMENT PLAN (Administer/Consume)

Drug Therapy Problems Categories Cipolle, Strand, Moley. Pharmaceutical Care Practice, 3 rd edition 8

Medication Adherence Barriers Does not understand instructions: the patient does not understand how to properly take or use the drug product and dosage regimen leading to the underuse of the medication Cannot afford drug product: the patient cannot afford the drug therapy recommended or prescribed Patient prefers not to take: the patient prefers not to take the drug therapy as instructed. Does not feel its needed. Concerned about side effects. Patient forgets to take: the patient does not remember to take sufficient doses of the medication Cannot swallow/administer drug: the patient is not able to swallow or administer the drug therapy as intended Substituting self-medication for prescribed medication or altering the use of prescribed medication in other ways due to the complementary use of self-medication

Example Meet Katherine Dicha 10 year old female Healthy except bronchial asthma Under care of Dr. Michael Admitted to hospital on 5 occasions over past four years with status asthmaticus 10

Today is July 10 and Mrs. Dicha has returned to the pharmacy for a refill of KD s albuterol 11

Asthma Deaths are Usually Preventable Literature indicates 3 major causes of asthma death: Delay in seeking or receiving appropriate care Medication misuse; poor adherence - under-use of corticosteroids and overuse of ß-agonists; interaction and toxicity Inappropriate care: insufficient corticosteroids Hindi Alexander MC, Middleton E,Jr. Asthma deaths: are they preventable? N Engl Reg Allergy Proc 1986; 7:462-466.

Overuse of inhaled ß-agonists associated with increased asthma death risk Matched 129 patients who had fatal or near-fatal asthma with 655 controls (who had received medications for asthma but had not had fatal or near- fatal events) with respect to region of residence, age, receipt of social assistance, and previous hospitalization for asthma. An increased risk of death or near death from asthma was associated with the regular use of inhaled beta 2- agonist bronchodilators. Heavy use of these agents should alert clinicians that it is necessary to reevaluate the patient's condition. Spitzer, W.O., et al.. N Engl J Med 326:501-506, 1992.

Use of inhaled steroids is associated with reduced asthma death risk Same sample and design as above, with the additional matching criterion of at least one hospitalization for asthma in the prior 2 years... subjects who had been dispensed, on average, one or more metered-dose inhalers of beclomethasone per month over a 1-year period had a significantly lower risk of fatal and near-fatal asthma (odds ratio, 0.1; 95% confidence interval, 0.02 to 0.6). Ernst, P.,et al.. JAMA 268:3462-3464, 1992.

THE PROBLEM About 50% of medications prescribed for chronic conditions are not taken as prescribed Adherence to controller medications varies among studies but most report adherence in the range from 17 to 50 percent based on refill records from pharmacies Dispensing data show patients treated with inhaled corticosteroids have, on average, only a two to four month supply of inhalers dispensed per year Despite the Work of Pharmacists

Refill Intervals for Albuterol MDI (Gainesville Florida) n=175 % of Total Refills 70 60 50 40 30 20 10 About 40% of refills were too soon. 0 (Actual data) 7 14 21 >21 Days from Last Refill

Refill Intervals for Beclomethasone MDI Florida) n=131 (Gainesville % of Total Refills 70 60 50 40 30 20 10 About 60% of refills were too late. 0 (Actual data) Very Early Early "On-Time" Late Very Late Time of Refill

Looking toward Prevention Do we need to change the medications use system?

The Ideal of Pharmaceutical Care responsible, cooperative provision of drug therapy for the purpose of achieving definite outcomes intended to improve a patient s quality of life 19

A DRUG THERAPY SYSTEM RECOGNIZE PATIENT PROBLEM PRESCRIBING INFLUENCE (EDUCATION, FORMULARIES, ETC.) CLINICAL IMPRESSION (DIAGNOSIS) PLAN Prescribe Medicine PRESCRIBING EVALUATION PRESCRIBING DATA DEFINE & RESOLVE DTPs before coming DRMs IMPLEMENT PLAN (DISPENSE, ADVISE) MONITOR PATIENT PROGRESS IMPLEMENT PLAN (ADMINISTER/CONSUME)

Today is July 10 and Mrs. Dicha has returned to the pharmacy for a refill of KD s albuterol 21

Today is July 10 and Mrs. Dicha has returned to the pharmacy for a refill of KD s albuterol 22

23

SUMMARY: KEY PROBLEMs with Asthma DTPs Indication for Controller medication in a poorly controlled patient with asthma but controller not prescribed Safety problem associated with overuse of albuterol, which masks the signs of worsening asthma disease Adherence associated with underuse of controller 70% of people show poor administration technique of inhalers Dr. House Despite the Work of Pharmacists

The Backstory For some, culturally derived beliefs and values about disease shape health behaviors Challenges in learning how patients really use their medications and the barriers they face

THE PROBLEM Adherence to controller medications in the range from 17 to 50 percent based on refill records from pharmacies CAM use for treating asthma for adults ranged from 4% to 79%, and for children from 33% to 89%. Most commonly used were breathing techniques, herbal products, homeopathy and acupuncture and higher use in certain ethnic populations When asked whether CAMs were effective for asthma, >50% report they were satisfied with the CAMs used CAMs used due to concerns about long-term effects of steroid use; frustration that asthma does not resolve with conventional therapies; dissatisfaction with physician-patient interactions; belief that CAM therapies are natural and therefore safe; and desire of patients to have autonomy in making health choices

THE PROBLEM Low-income inner-city Black adults tended to use CAMs along with conventional asthma treatment, and considered CAM as natural, effective and potentially curative even while most of them said they also trusted prescribed asthma medicines. However, many admitted they were often not adherent to medications prescribed to control asthma. Significantly, several studies about the use of CAM for treating asthma found that most patients did not tell their healthcare providers they were using CAMs.

Training Objectives Describe and understand the CHW- MTM care process, role of the CHW and other health care providers. Create an accurate and complete personal medication list that includes prescription, OTC, Herbals, and home remedies. Gather accurate, understandable and complete health care information that will enable providers to make appropriate therapeutic decisions. Apply Motivational Interviewing skills to the medication history and patient interviewing Determine medication adherence, reasons for nonadherence and potential solutions through the analysis of the prescription claims data, patient interview, administration and interpretation of a set of questions to reveal medication use patterns and barriers. Create a care plan that provides clear, concise and credible actions for the client. Be HIPAA compliant Know when, which and how to refer the client to appropriate providers and/or support organizations. https://www.youtube.com/watch?v=469jyynxqcw

CHW CHW and the Pharmacist Gathering Discovering Presenting Collaborating Implementing Pharmacist Reviewing Evaluating Problem Solving Collaboration

Molina CHW Program

Building and Intervention Toolkit Financial Assistance Regimen Simplification Refill Synchronization Connect to CHW Access to Meds Prescriber Correspondence Patient Education Connect to Community Pharmacist Mail Order Delivery 90 Day Supply Reminder Tools

We are in this together